Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings    ZBH

ZIMMER BIOMET HOLDINGS

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Zimmer: 2Q Earnings Snapshot

08/04/2020 | 06:46am EST

WARSAW, Ind. (AP) _ Zimmer Biomet Holdings Inc. (ZBH) on Tuesday reported a second-quarter loss of $206.6 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Warsaw, Indiana-based company said it had a loss of $1. Earnings, adjusted for non-recurring costs, came to 5 cents per share.

The results beat Wall Street expectations. The average estimate of 13 analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share.

The orthopedic device maker posted revenue of $1.23 billion in the period, which also beat Street forecasts. Ten analysts surveyed by Zacks expected $930.9 million.

Zimmer shares have declined slightly more than 9% since the beginning of the year. The stock has dropped slightly more than 1% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZBH at https://www.zacks.com/ap/ZBH

© 2020 The Canadian Press. All rights reserved., source Canadian Press DataFile

All news about ZIMMER BIOMET HOLDINGS
11/18ZIMMER BIOMET : to Present at 2020 Evercore ISI HealthCONx Conference and Piper ..
AQ
11/17ZIMMER BIOMET : to Present at 2020 Evercore ISI HealthCONx Conference and Piper ..
PR
11/09ZIMMER BIOMET : Announces Third Quarter 2020 Financial Results
AQ
11/06ZIMMER BIOMET : Management's Discussion and Analysis of Financial Condition and ..
AQ
11/06ZIMMER : 3Q Earnings Snapshot
AQ
11/06ZIMMER BIOMET HOLDINGS, INC. : Results of Operations and Financial Condition (fo..
AQ
11/06ACELRX PHARMACEUTICALS : Reports Third Quarter 2020 Financial Results
AQ
11/06ZIMMER BIOMET : Announces Preliminary Results from mymobility Clinical Study at ..
AQ
11/06ZIMMER BIOMET : Announces Third Quarter 2020 Financial Results
PR
11/05BACTIGUARD : Interim report for Q3 2020
AQ
More news
Financials (USD)
Sales 2020 7 059 M - -
Net income 2020 -167 M - -
Net Debt 2020 6 769 M - -
P/E ratio 2020 -183x
Yield 2020 0,65%
Capitalization 31 025 M 31 025 M -
EV / Sales 2020 5,35x
EV / Sales 2021 4,49x
Nbr of Employees 19 900
Free-Float 66,5%
Chart ZIMMER BIOMET HOLDINGS
Duration : Period :
Zimmer Biomet Holdings Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 157,07 $
Last Close Price 149,68 $
Spread / Highest target 16,9%
Spread / Average Target 4,94%
Spread / Lowest Target -29,2%
EPS Revisions
Managers
NameTitle
Bryan C. Hanson President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Kenneth R. Tripp Senior VP-Global Operations & Logistics
Suketu P. Upadhyay Executive VP, Chief Financial & Accounting Officer
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS0.00%31 025
ABBOTT LABORATORIES22.51%188 597
MEDTRONIC PLC-0.12%151 957
BECTON, DICKINSON AND COMPANY-16.36%65 973
HOYA CORPORATION32.49%49 699
BAXTER INTERNATIONAL INC.-9.84%38 511